Increased Risk of RSV Infection in Children with Down's Syndrome: Clinical Implementation of Prophylaxis in the European Union

Figure 4

Answers to the following question: Can you give an estimation of the percentage of children in your country/state receiving RSV prophylaxis among the following groups? Answer options are given as follows: I do not know, almost never (0%–5%), rarely (5%–10%), regularly (>10%); <32 weeks: children with DS born prematurely gestational age <32 weeks (missing data: 𝑛=10, 18.9%); <35 weeks: children with DS born prematurely gestational age <35 weeks (missing data: 𝑛=12, 22.6%), CHD: children with DS and congenital heart disease (missing data: 𝑛=10, 18.9%); healthy: otherwise healthy children with DS (missing data: 𝑛=12, 22.6%).